Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish with gradual dose titration
People who have a fever, productive cough, or are feeling generally unwell shouldnt donate
Many patients combine GPL-1 with IV Therapy, Hormone Replacement, and Body Contouring for enhanced results
doi: 10.1111/j.1471-4159.2004.02914.x 53 TurtonMDOSheaDGunnIBeakSAEdwardsCMMeeranKet al
Patients with a body mass index (BMI) of 30 or higher, or BMI of 27 or higher with weight-related health conditions like hypertension or type 2 diabetes, generally qualify for GLP-1 treatment
As mentioned at the beginning, the NL-GHK-Cu peptide increases the expression of antioxidant genes and inhibits the expression of pro-oxidant genes, which prevents and slows the risk of cataract occurrence, both acquired and congenital